The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit
Open accessAbstract
BACKGROUND: Studies that have evaluated the use of intravenous vitamin C in adults with sepsis who were receiving vasopressor therapy in the intensive care unit (ICU) have shown mixed results with respect to the risk of death and organ dysfunction. METHODS: In this randomized, placebo-controlled trial, we assigned adults who had been in the ICU for no longer than 24 hours, who had proven or suspected infection as the main diagnosis, and who were receiving a vasopressor to receive an infusion of either vitamin C (at a dose of 50 mg per kilogram of body weight) or matched placebo administered every 6 hours for up to 96 hours. The primary outcome was a composite of death or persistent organ dysfunction (defined by the use of vasopressors, invasive mechanical ventilation, or new renal-replacement therapy) on day 28. RESULTS: A total of 872 patients underwent randomization (435 to the vitamin C group and 437 to the control group). The primary outcome occurred in 191 of 429 patients (44.5%) in the vitamin C group and in 167 of 434 patients (38.5%) in the control group (risk ratio, 1.21; 95% confidence interval [CI], 1.04 to 1.40; P = 0.01). At 28 days, death had occurred in 152 of 429 patients (35.4%) in the vitamin C group and in 137 of 434 patients (31.6%) in the placebo group (risk ratio, 1.17; 95% CI, 0.98 to 1.40) and persistent organ dysfunction in 39 of 429 patients (9.1%) and 30 of 434 patients (6.9%), respectively (risk ratio, 1.30; 95% CI, 0.83 to 2.05). Findings were similar in the two groups regarding organ-dysfunction scores, biomarkers, 6-month survival, health-related quality of life, stage 3 acute kidney injury, and hypoglycemic episodes. In the vitamin C group, one patient had a severe hypoglycemic episode and another had a serious anaphylaxis event. CONCLUSIONS: In adults with sepsis receiving vasopressor therapy in the ICU, those who received intravenous vitamin C had a higher risk of death or persistent organ dysfunction at 28 days than those who received placebo. (Funded by the Lotte and John Hecht Memorial Foundation; LOVIT ClinicalTrials.gov number, NCT03680274.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A systematic review and meta-analysis of 2124 patients, with 1274 on pulmonary hypertension specific agents demonstrated only small quality of life benefits in patients with PH and IPF, thus there is insufficient evidence to support their widespread use [119].”
From Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF) (2024) · cites this paper as [119]
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Self-citationAPACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795
A global clinical measure of fitness and frailty in elderly people
Rockwood, K. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050051 · Cited by 8,968
Rudd, K. E., Johnson, S. C., Agesa, K. M., Shackelford, K. A., Tsoi, D., Kievlan, D. R., Colombara, D. V., Ikuta, K. S., Kissoon, N., Finfer, S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32989-7 · Cited by 7,971
Hospital Deaths in Patients With Sepsis From 2 Independent Cohorts
Liu, V., Escobar, G. J., Greene, J. D., Soule, J., Whippy, A., Angus, D. C., & Iwashyna, T. J. (2014) · JAMA · doi:10.1001/jama.2014.5804 · Cited by 977
A Randomized Trial of Glutamine and Antioxidants in Critically Ill Patients
Heyland, D., Muscedere, J., Wischmeyer, P. E., Cook, D., Jones, G., Albert, M., Elke, G., Berger, M. M., & Day, A. G. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212722 · Cited by 904
Self-citationHydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock
Marik, P. E., Khangoora, V., Rivera, R., Hooper, M. H., & Catravas, J. (2017) · Chest · doi:10.1016/j.chest.2016.11.036 · Cited by 887
Fowler, A. A., Truwit, J. D., Hite, R. D., Morris, P. E., DeWilde, C., Priday, A., Fisher, B., Thacker, L. R., Natarajan, R., Brophy, D. F., et al. (2019) · JAMA · doi:10.1001/jama.2019.11825 · Cited by 836
Schandelmaier, S., Briel, M., Varadhan, R., Schmid, C. H., Devasenapathy, N., Hayward, R. A., Gagnier, J., Borenstein, M., van der Heijden, G. J. M. G., Dahabreh, I. J., et al. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.200077 · Cited by 749
Self-citationPost-randomisation exclusions: the intention to treat principle and excluding patients from analysis
Fergusson, D., Aaron, S. D., Guyatt, G., & Hébert, P. (2002) · BMJ · doi:10.1136/bmj.325.7365.652 · Cited by 708
Self-citationPhase I safety trial of intravenous ascorbic acid in patients with severe sepsis.
Nursing, M. R. I. C. U., Fowler, A. A., Syed, A. A., Knowlson, S., Sculthorpe, R., Farthing, D., DeWilde, C., Farthing, C. A., Larus, T. L., Martin, E., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-32 · Cited by 573
Influence of trial sample size on treatment effect estimates: meta-epidemiological study
Dechartres, A., Trinquart, L., Boutron, I., & Ravaud, P. (2013) · BMJ · doi:10.1136/bmj.f2304 · Cited by 544
Ferreira-González, I., Permanyer-Miralda, G., Domingo-Salvany, A., Busse, J. W., Heels-Ansdell, D., Montori, V. M., Akl, E. A., Bryant, D. M., Alonso-Coello, P., Alonso, J., et al. (2007) · BMJ · doi:10.1136/bmj.39136.682083.ae · Cited by 473
Self-citationCarr, A. C., Rosengrave, P. C., Bayer, S., Chambers, S., Mehrtens, J., & Shaw, G. M. (2017) · Critical Care · doi:10.1186/s13054-017-1891-y · Cited by 413
Ascorbate: The Most Effective Antioxidant in Human Blood Plasma
Frei, B., Stocker, R., England, L., & Ames, B. N. (1990) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4684-5730-8_24 · Cited by 283
Sevransky, J. E., Rothman, R. E., Hager, D. N., Bernard, G. R., Brown, S. M., Buchman, T. G., Busse, L. W., Coopersmith, C. M., DeWilde, C., Ely, E. W., et al. (2021) · JAMA · doi:10.1001/jama.2020.24505 · Cited by 283
Ferreira-González, I., Permanyer-Miralda, G., Busse, J. W., Bryant, D. M., Montori, V. M., Alonso-Coello, P., Walter, S. D., & Guyatt, G. H. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.10.020 · Cited by 221
Self-citationTang, Z., Du, X., Louie, R. F., & Kost, G. J. (2000) · American Journal of Clinical Pathology · doi:10.1309/qaw1-x5xw-bvrq-5lkq · Cited by 207
To condition or not condition? Analysing ‘change’ in longitudinal randomised controlled trials
Coffman, C. J., Edelman, D., & Woolson, R. F. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-013096 · Cited by 204
Acute haemolysis induced by high dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency.
Rees, D. C., Kelsey, H., & Richards, J. D. (1993) · BMJ · doi:10.1136/bmj.306.6881.841 · Cited by 191
Vitamin C Pharmacokinetics in Critically Ill Patients
de Grooth, H.-J., Manubulu-Choo, W.-P., Zandvliet, A. S., Spoelstra - de Man, A. M. E., Girbes, A. R., Swart, E. L., & Oudemans-van Straaten, H. M. (2018) · Chest · doi:10.1016/j.chest.2018.02.025 · Cited by 164
Accounting for centre-effects in multicentre trials with a binary outcome – when, why, and how?
Kahan, B. C. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-20 · Cited by 158
Vitamin therapy in critically ill patients: focus on thiamine, vitamin C, and vitamin D
Amrein, K., Straaten, H. M. O., & Berger, M. M. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5107-y · Cited by 127
Fujii, T., Salanti, G., Belletti, A., Bellomo, R., Carr, A. C., Furukawa, T. A., Luethi, N., Luo, Y., Putzu, A., Sartini, C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06558-0 · Cited by 118
Self-citationPersistent organ dysfunction plus death: a novel, composite outcome measure for critical care trials
Heyland, D. K., Muscedere, J., Drover, J., Jiang, X., Day, A. G., & the Canadian Critical Care Trials Group (2011) · Critical Care · doi:10.1186/cc10110 · Cited by 57
Self-citationIV Vitamin C in Critically Ill Patients: A Systematic Review and Meta-Analysis.
Patel, J. J., Ortiz‐Reyes, L., Dhaliwal, R., Clarke, J., Hill, A., Stoppe, C., Lee, Z., & Heyland, D. K. (2022) · PubMed · doi:10.1097/ccm.0000000000005320 · Cited by 29
Self-citationLessening Organ dysfunction with VITamin C (LOVIT): protocol for a randomized controlled trial
on behalf of the Canadian Critical Care Trials Group, Masse, M.-H., Ménard, J., Sprague, S., Battista, M., Cook, D. J., Guyatt, G. H., Heyland, D. K., Kanji, S., Pinto, R. L., et al. (2020) · Trials · doi:10.1186/s13063-019-3834-1 · Cited by 28
Self-citationLachance, O., Goyer, F., Adhikari, N. K. J., Masse, M.-H., Bilodeau, J., Lamontagne, F., & Leclair, M.-A. (2021) · Journal of Medical Case Reports · doi:10.1186/s13256-021-02869-4 · Cited by 11
Self-citationLessening Organ Dysfunction With Vitamin C (LOVIT) Trial: Statistical Analysis Plan
Adhikari, N. K. J., Pinto, R. L., Day, A. G., Masse, M.-H., Ménard, J., Sprague, S., Annane, D., Arabi, Y. M., Battista, M., Cohen, D., et al. (2022) · JMIR Research Protocols · doi:10.2196/36261 · Cited by 10
Self-citation
Research works printed but not linked: 1
- Kellum JA, Lameire N, Aspelin P, et al. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2:Suppl 1:1-38.
Cited by
ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit
Singer, P., Blaser, A. R., Berger, M. M., Calder, P. C., Casaer, M., Hiesmayr, M., Mayer, K., Montejo-Gonzalez, J. C., Pichard, C., Preiser, J.-C., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.07.011 · Cited by 793
Vincent, J.-L. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.104318 · Cited by 208
Therapeutic advances in COVID-19
Murakami, N., Hayden, R., Hills, T. E., Al-Samkari, H. T., Casey, J. D., Sorbo, L. D., Lawler, P. R., Sise, M. E., & Leaf, D. E. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00642-4 · Cited by 173
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08361-1 · Cited by 141
Self-citationTargeting the host response in sepsis: current approaches and future evidence
Bode, C., Weis, S., Sauer, A., Wendel‐Garcia, P. D., & David, S. (2023) · Critical Care · doi:10.1186/s13054-023-04762-6 · Cited by 131
Metadata
- Authors
- Lamontagne, F., Masse, M.-H., Menard, J., Sprague, S., Pinto, R., Heyland, D. K., Cook, D. J., Battista, M.-C., Day, A. G., Guyatt, G. H., Kanji, S., Parke, R., McGuinness, S. P., Tirupakuzhi Vijayaraghavan, B.-K., Annane, D., Cohen, D., Arabi, Y. M., Bolduc, B., Marinoff, N., Rochwerg, B., Millen, T., Meade, M. O., Hand, L., Watpool, I., Porteous, R., Young, P. J., D’Aragon, F., Belley-Cote, E. P., Carbonneau, E., Clarke, F., Maslove, D. M., Hunt, M., Chassé, M., Lebrasseur, M., Lauzier, F., Mehta, S., Quiroz-Martinez, H., Rewa, O. G., Charbonney, E., Seely, A. J. E., Kutsogiannis, D. J., LeBlanc, R., Mekontso-Dessap, A., Mele, T. S., Turgeon, A. F., Wood, G., Kohli, S. S., Shahin, J., Twardowski, P., & Adhikari, N. K. J.
- Affiliations
- Université de Sherbrooke (CA)
- Centre Hospitalier Universitaire de Sherbrooke (CA)
- Research Centre of the Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC, Canada J1H 5N4
- McMaster University (CA)
- Sunnybrook Health Science Centre (CA)
- Queen's University (CA)
- St. Joseph’s Healthcare Hamilton (CA)
- Ottawa Hospital (CA)
- University of Auckland (NZ)
- Auckland City Hospital (NZ)
- Department of Critical Care Medicine, Apollo Hospitals, Chennai, India
- Inserm (FR)
- Bishop's University (CA)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- Juravinski Hospital (CA)
- Hamilton Health Sciences (CA)
- Ottawa Hospital Research Institute (CA)
- Apollo Hospitals (IN)
- McMaster University, Department of Medicine, Hamilton, ON, Canada L8N 3Z5
- Centre Hospitalier de l’Université de Montréal (CA)
- Université Laval (CA)
- University of Toronto (CA)
- University of Alberta (CA)
- Hôpital du Sacré-Cœur de Montréal (CA)
- University of Ottawa (CA)
- Université de Sherbrooke, Department of Medicine, Sherbrooke, QC, Canada J1H 5N4
- AP-HP, Hôpitaux Universitaires Henri-Mondor, Service de Médecine Intensive Réanimation Creteil, Île-de-France, FR 94000
- Western University (CA)
- Island Health (CA)
- McGill University Health Centre (CA)
- University of Otago, Department of Surgical Sciences, Dunedin, NZ 9054
- ORCID
- Lamontagne, François
- Masse, Marie-Hélène
- Sprague, Sheila
- Pinto, Ruxandra
- Heyland, Daren K.
- Battista, Marie-Claude
- Day, Andrew G.
- Guyatt, Gordon H.
- Kanji, Salmaan
- Parke, Rachael
- McGuinness, Shay P.
- Annane, Djillali
- Cohen, Dian
- Arabi, Yaseen M.
- Rochwerg, Bram
- Meade, Maureen O.
- Watpool, Irene
- Porteous, Rebecca
- Young, Paul J.
- Clarke, France
- Maslove, David M.
- Chassé, Michaël
- Lauzier, François
- Mehta, Sangeeta
- Rewa, Oleksa G.
- Charbonney, Emmanuel
- Seely, Andrew J.E.
- Kutsogiannis, Demetrios J.
- Mele, Tina S.
- Turgeon, Alexis F.
- Wood, Gordon
- Shahin, Jason
- Adhikari, Neill K.J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2022-06-23
- Volume
- 386
- Issue
- 25
- Pages
- 2387-2398
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4282975062
- Cited by
- 350
- References
- 31
- Citations by year
- 2026: 58 · 2025: 79 · 2024: 75 · 2023: 98 · 2022: 40
- FWCI
- 45.02
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- The Lotte & John Hecht Memorial Foundation (4318)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Keywords
- intravenous vitamin C, vitamin C, vasopressor therapy, intensive care unit, mortality, organ dysfunction, acute kidney injury, hypoglycemia, anaphylaxis, sepsis treatment, critically ill adults, health-related quality of life, 6-month survival, biomarkers, organ dysfunction scores
- MeSH terms
- Adult, Ascorbic Acid, Humans, Hypoglycemic Agents, Intensive Care Units, Multiple Organ Failure, Quality of Life, Vasoconstrictor Agents, Vitamins, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.